Carlos Planell Dosal in Lares, Puerto Rico

Home Puerto Rico Lares

Carlos Planell Dosal has General Practice as his primary medical specialty. Their primary office is: State Rd in Lares, Puerto Rico. They attended Sorry, his university is not listed and graduated in 2007 (around 17 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Carlos F Planell Dosal Office Phone and Directions

Carlos Planell Dosal
State Rd
Lares, Puerto Rico 00669
787-897-7866

Patient Ratings
Please rate your experience with Carlos Planell Dosal below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 787-897-7866

Enter a starting address:

Healthcare Info for Carlos Planell Dosal

Medical School: Sorry, his university is not listed
Graduation Year: 2007
The Primary Medical Specialty for Carlos Planell Dosal is listed as: General Practice
Approximate Years of Experience: 17
PAC (PECOS ID)#: 5496879892
NPI #: 1356667786
NPI Created On: 04/09/2010
NPI Last Updated Listed as: 08/06/2019
Primary Taxonomy Code: 1223G0001X

URL not found for state: PR licensing board.
License Number:
17869
Listed Gender: Male

Procedures, Services, Charges

Services and Procedures include:

Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 843666727

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Endocrine & Metabolic Diseases

Name of Drug #1: SOLIQUA 100/33

Open Associated Drug #1: 0024-5761-05